|
Real-time Estimate
Cboe BZX
15:59:52 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 2.140 USD | -4.04% |
|
+0.70% | -37.72% |
| 08-24 | Grace Therapeutics Files for Resale of Up to 4.8 Million Shares | MT |
| 08-13 | Grace Therapeutics, Inc. Reports Impairment charges for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.04% | +0.70% | -0.23% | -2.93% | -37.72% | -30.26% | +7.21% | -83.45% | -97.76% | 46.91M | |
| +0.66% | +0.87% | -0.96% | +58.71% | +74.00% | +47.39% | +97.63% | +11.27% | - | 69.18B | |
| -1.19% | -1.99% | +16.21% | +11.48% | +18.39% | +33.01% | +73.08% | +211.99% | +5,664.95% | 62B | |
| +2.22% | -4.63% | -4.27% | +28.60% | -29.42% | -15.14% | +362.67% | +357.33% | +743.10% | 26.19B | |
| +1.46% | +1.30% | +10.63% | +61.51% | +58.84% | +28.58% | +13.76% | -57.46% | - | 25.75B | |
| -1.79% | -2.77% | +4.16% | +6.60% | +0.22% | -3.88% | -12.50% | -74.40% | - | 24.29B | |
| +2.84% | +3.61% | +5.09% | +42.10% | +9.08% | +24.60% | -15.06% | -16.94% | +100.45% | 19.84B | |
| 0.00% | -14.23% | -19.67% | +40.41% | +184.40% | +170.04% | +298.75% | +1,445.16% | +733.35% | 15.65B | |
| -0.46% | -0.83% | +36.11% | +25.32% | -0.54% | -4.00% | +861.05% | +168.03% | +192.35% | 13.88B | |
| -0.39% | -5.61% | -11.51% | +9.88% | +17.44% | -9.51% | +483.04% | - | - | 14.09B | |
| -0.23% | -3.22% | +7.89% | +8.35% | +28.79% | +44.23% | +164.40% | +174.83% | +316.61% | 14.1B | |
| +0.87% | -4.01% | -0.02% | +4.70% | -9.89% | +22.88% | +220.78% | +554.70% | +5,227.31% | 12.09B | |
| -6.91% | -21.30% | -26.69% | -15.05% | -2.05% | +121.04% | +131.18% | +2.15% | +818.50% | 9.98B | |
| -5.09% | -6.03% | -5.83% | +1.18% | -20.00% | -29.87% | +139.47% | +104.29% | - | 11.18B | |
| -2.99% | +36.39% | +20.92% | +44.11% | +260.85% | +94.19% | +22.21% | -92.21% | - | 1.46B | |
| +0.14% | -7.07% | -9.23% | -8.43% | +8.39% | +38.40% | +103.34% | +105.64% | +697.11% | 9.64B | |
| -3.26% | -2.85% | -1.14% | +16.52% | +295.45% | +178.65% | +368.86% | -19.61% | - | 8.63B | |
| -0.78% | -1.62% | -2.78% | +18.73% | +26.89% | +87.46% | +15.27% | +122.01% | - | 8.81B | |
| -2.12% | -5.32% | -8.49% | +2.36% | +2.57% | -33.11% | +88.39% | -25.25% | - | 8.08B | |
| +0.26% | +5.20% | -12.57% | +9.64% | +179.15% | +517.07% | +636.91% | -48.41% | -52.56% | 8.02B | |
| Average | -1.01% | -1.10% | -0.12% | +18.19% | +53.24% | +64.09% | +203.02% | +149.46% | +1,303.95% | 18.15B | |
| Weighted average by Cap. | -0.27% | -1.63% | +2.35% | +26.59% | +41.50% | +46.85% | +170.82% | +161.02% | +2,449.68% |
- Stock Market
- Stocks
- GRCE Stock
- Sector Grace Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
